These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost? Black C; Paterson KR Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):277-303. PubMed ID: 11770173 [No Abstract] [Full Text] [Related]
4. Consensus on anti-platelet therapy in peripheral arterial disease: saving lives and limbs. Donnelly R; Collinson DJ Platelets; 2003; 14(7-8):403-6. PubMed ID: 14713508 [No Abstract] [Full Text] [Related]
5. [Myocardial infarct, stroke and vascular events reduced by a third]. Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253 [No Abstract] [Full Text] [Related]
6. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389 [No Abstract] [Full Text] [Related]
7. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both? Mohler ER Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065 [TBL] [Abstract][Full Text] [Related]
8. [Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years]. MMW Fortschr Med; 2003 Apr; 145(15):63. PubMed ID: 15104272 [No Abstract] [Full Text] [Related]
11. Is aspirin still the antiplatelet drug of choice for patients with peripheral arterial disease? Matsagas MI; Jagroop IA; Mikhailidis DP; Geroulakos G Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):281-2. PubMed ID: 12624855 [No Abstract] [Full Text] [Related]
12. Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting. Duran E; Canbaz S; Ege T; Acipayam M Platelets; 2001 Dec; 12(8):503-4. PubMed ID: 11798400 [No Abstract] [Full Text] [Related]
13. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease. Cavendish JJ; Safani M Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486 [TBL] [Abstract][Full Text] [Related]
14. Growth in clopidogrel-aspirin combination therapy. Brinker AD; Swartz L Ann Pharmacother; 2006 Jun; 40(6):1212-3. PubMed ID: 16684805 [No Abstract] [Full Text] [Related]
15. [Challenges and perspectives of antiplatelet therapy in the secondary prevention of vascular events]. Fernández-Concepción O; González-García S Rev Neurol; 2010 Jan 1-15; 50(1):59-61. PubMed ID: 20073026 [No Abstract] [Full Text] [Related]
17. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy? Milani RV Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy for patients with stents. Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203 [No Abstract] [Full Text] [Related]
19. The (variable) definition of benefit in the case of clopidogrel vs aspirin. Hansen DB Arch Intern Med; 2005 Jun; 165(11):1310; author reply 1310-1. PubMed ID: 15956013 [No Abstract] [Full Text] [Related]